ArticleLeukemia & lymphoma2025

Real-world treatment adherence and persistence of FLT3 inhibitors as post-alloHCT maintenance therapy in patients with AML in the United States: a cohort study using administrative claims data.

Vanessa E Kennedy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.